Ethicon US LLC, Pfizer Inc. and C.R. Bard Inc., Dominated the Market for Global Hemostats Market in 2017-2024
The Global Hemostats Market is highly concentrated market with major key players and local players to cater the domestic market. Ethicon US LLC dominated the hemostats market accounting for the highest market share in 2016, followed by Pfizer Inc., and C.R. Bard Inc. Other players in the market include Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, MedTrade Products Limited., Integra LifeSciences Corporation, Medline Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker, CSL Behring, Mallinckrodt, and Equimedical, B.V. holds a share of 15.3% of the global hemostats market in 2016.
Request for Sample Report Visit @: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemostats-market
ETHICON US, LLC (SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC):
Founded in 1886 and headquartered at New Brunswick, New Jersey, U.S., Ethicon US, LLC., a subsidiary of Johnson & Johnson Services, Inc. is engaged in the development and marketing of healthcare products. The company operates through three business segments- Consumer, Pharmaceutical, and Medical Devices.
1. In June, 2017 Ethicon US, LLC received FDA approval for SURGICEL powder absorbable hemostat. This hemostat powder will help surgeons to have a simple and predictable adjunctive hemostatic solution to control continuous oozing on broad or raw surfaces.
2. In August, 2016 Ethicon US, LLC collaborated with Touch Surgery to improve patient’s condition through Ethicon surgical products.
Inquiry for TOC about the Global Hemostats Market Visit @: http://databridgemarketresearch.com/toc/?dbmr=global-hemostats-market
Founded in 1849 and headquartered in New York, U.S., Pfizer Inc., is engaged in discovering, developing and, manufacturing of healthcare products. Pfizer operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment concentrates on creating and commercializing immunizations and prescriptions that enhance patients' lives, and in addition products for the end user health care. The EH segment includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems, inadditon to research and development.
View Full Report Visit @ http://databridgemarketresearch.com/reports/global-hemostats-market/
Founded in 1907 and headquartered at Murray Hill, New Jersey, USA, C. R. Bard, Inc. is engaged in the development, manufacturing and marketing of medical technologies. The company operates through four business segments- vascular, urology, oncology, and surgical specialties.
1. In August, 2013 C. R. Bard, Inc. acquired Medafor, Inc. a leading developer and supplier of plant based hemostatic agents. This acquisition would enhance the company's business opportunities.
Germany Fitness Equipment Market – Trends and Forecast to 2024
Germany Fitness Equipment Market, By Type (namely body composition analyzers, fitness monitoring equipment, cardiovascular training equipment and strength training equipment) By Product Type(Bioimpedance analyzers, skinfold caliper, dual emission x-ray absorptiometry (DEXA), hydrostatic weighing and, air displacement plethysmography), By End User (health clubs/ gyms, home settings, corporate settings, hotels, apartments, hospitals, clinics), By Geography (Germany) – Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/germany-fitness-equipment-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ethicon US LLC, Pfizer Inc. and C.R. Bard Inc., Dominated the Market for Global Hemostats Market in 2017-2024 here
News-ID: 741023 • Views: 257
More Releases from Data Bridge Market Research
Global Pharmaceutical Logistics Market Outlook 2020-In-Depth Insight Of Sales A …
Global pharmaceutical logistics market is expected to rise to an estimated value of USD 98.19 billion by 2026, registering a steady CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the growing demand for more effective and efficient logistics service amid a rise in consumption of pharmaceutical products. Few of the major competitors currently working in the global pharmaceutical logistics market are Agility;
Global medical aesthetics market Outlook 2020-In-Depth Insight Of Sales Analysi …
Global Medical Aesthetics Market By Product type (Aesthetic Lasers, Energy Devices, Body Contouring Devices, Facial Aesthetic Devices, Aesthetic Implants, Skin Aesthetic Devices), Application (Anti-Aging and Wrinkles, Facial and Skin Rejuvenation, Breast Enhancement, Body Shaping and Cellulite, Tattoo Removal, Vascular Lesions, Psoriasis and Vitiligo, Others), End User (Cosmetic Centres, Dermatology Clinics, Hospitals, Medical Spas and Beauty Centres), Distribution Channel (Direct Tender, Retail), Geography (North America, South America, Europe, Asia-Pacific, Middle East
Pharma Clinical Trial Digitization Market Outlook 2020-In-Depth Insight Of Sales …
Global Pharma Clinical Trial Digitization Market report brings into light key market dynamics of the sector along with the current market scenario and future prospects of the sector. This market analysis report is a scrupulous analysis of current scenario of the market, which covers several market dynamics. Company snapshot, geographical presence, product portfolio, and recent developments are taken into consideration for studying the company profiles. The meticulous efforts accompanied with
Global HEALTHCARE ADDITIVE MANUFACTURING Market Outlook 2020-In-Depth Insight Of …
"This HEALTHCARE ADDITIVE MANUFACTURING Market report is an important document for every market enthusiast, policymaker, investor, and market player. The report suggests that the market has shown rapid development in the current and past years and is going to progress with continuing growth in the upcoming years. This market research report gives explanation about the strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing
More Releases for Hemostats
Global Hemostats and Tissue Sealants Market
Global Hemostats and Tissue Sealants Market –Industry Analysis and Forecast 2018-2026 – By Product Type, Application, End-user, and Region. Global Hemostats and Tissue Sealants Market was valued US$ 2.78 Bn in 2017 and is expected to reach US$ 5.29 Bn by 2026, at a CAGR of 8.37% during a forecast period. Increasing incidence of chronic diseases, the wide range of applications, patient safety & quick recovery, number of surgeries and growing aging
Hemostats Market worth $3.03 billion by 2023
According to the new market research “"Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023", The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Don’t miss out on business opportunities in Hemostats Market . Speak to our
Hemostats Market: Challenges and Opportunities Report 2019
Hemostat is a surgical tool used to control bleeding during surgery. Hemostats are applied by the means of tissue sealants and tissue adhesion agents. Tissue sealants and adhesives are mainly classified into two types namely, physical agents and biological substrates. Tissue sealants, tissue adhesives and adhesion prevention products are rapidly replacing conventional sutures for wound and incision closure. Advantages of tissue sealants, tissue adhesives and adhesion prevention products over conventional
Hemostats - Medical Devices Pipeline Assessment, 2016
Publisher's Medical Devices sector report, "Hemostats - Medical Devices Pipeline Assessment, 2016" provides an overview of Hemostats currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end
Hemostats - Medical Devices Pipeline Assessment, 2016
Summary Publisher's Medical Devices sector report, "Hemostats - Medical Devices Pipeline Assessment, 2016" provides an overview of Hemostats currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end
Global Hemostats Market Research and Analysis 2024
The new industry report “Global Hemostats Market 2017” is expected to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, growing at a CAGR of 6.6% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Thrombin based hemostats market has the largest market segment